FMB
BIIB icon

Field & Main Bank’s Biogen BIIB Stock Holding History

Field & Main Bank’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-75
Closed -$18K – 199
2019
Q2 		$18K Hold
75
– – 0.02% 173
2019
Q1 		$18K Buy
+75
New +$23.6K 0.02% 168
2018
Q3 		$35K Hold
100
– – 0.03% 168
2018
Q2 		$33K Sell
100
-200
-67% -$56.2K 0.03% 170
2018
Q1 		$82K Hold
300
– – 0.08% 135
2017
Q4 		$96K Buy
+300
New +$96.2K 0.09% 129

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Field & Main Bank's BIIB Position: Q3 2019 in Review

Field & Main Bank sold out of Biogen (BIIB) in Q3 2019, closing a stake of 75 shares — an estimated $18K sold.

Field & Main Bank first reported a position in BIIB in Q4 2017 and held it in 6 quarters. The position peaked at $96K in Q4 2017. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

  • Field & Main Bank reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
  • Field & Main Bank sold 75 Biogen shares in Q3 2019, an estimated $18K.
  • Field & Main Bank first reported a position in Biogen in Q4 2017 and held it in 6 quarters.
  • Field & Main Bank's Biogen position peaked at $96K in Q4 2017.
  • 989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Field & Main Bank's 13F filing for Q3 2019, filed 7 Nov 2019.